Eyetube Back Button
Alcon on Eyetube Logo
Cataract Glaucoma Retina
Alcon Interventional Glaucoma
Hydrus® Microstent Voyager™ DSLT

Unlock First-Line Glaucoma Care1

Play DSLT as Primary Treatment for Glaucoma

DSLT as Primary Treatment for Glaucoma

Learn more about direct selective laser trabeculoplasty (DSLT) with the Voyager DSLT (Alcon) and see how having an automated and noncontact method for glaucoma treatment allows for a comfortable experience for doctors and patients.

Watch Now

Videos

Play Interventional Glaucoma with Voyager DSLT

Interventional Glaucoma with Voyager DSLT

Deborah Ristvedt, DO, comments on the interventional glaucoma mindset and proactively treating patients with direct selective laser trabeculoplasty (DSLT). She reviews the impact of the Voyager DSLT (Alcon) on efficient and effective patient care in her practice.
Play Patient Experience with Voyager DSLT

Patient Experience with Voyager DSLT

See the Voyager DSLT (Alcon) in action as expert surgeons use the direct selective laser trabeculoplasty device on real-world patients, demonstrating the device’s efficiency and comfort in glaucoma care.
Play Talking to Patients About Laser-First Glaucoma Treatment

Talking to Patients About Laser-First Glaucoma Treatment

Lorraine M. Provencher, MD, explains how she consults patients about direct selective laser trabeculoplasty (DSLT) with the Voyager DSLT (Alcon). She highlights the benefits of the device for eliminating treatment barriers for patients, emphasizing ergonomics and patient comfort.
Play Patient Communication and Staff Training for DSLT

Patient Communication and Staff Training for DSLT

Paul Singh, MD, shares how he talks to patients about direct selective laser trabeculoplasty (DSLT) with the Voyager DSLT (Alcon). He also comments on his approach to staff training for the procedure.
Play DSLT Patient Experience

DSLT Patient Experience

Patients comment on their experiences with direct selective laser trabeculoplasty (DSLT) treatment.
Play DSLT as Primary Treatment for Glaucoma

DSLT as Primary Treatment for Glaucoma

Learn more about direct selective laser trabeculoplasty (DSLT) with the Voyager DSLT (Alcon) and see how having an automated and noncontact method for glaucoma treatment allows for a comfortable experience for doctors and patients.
Play Efficiency and Efficacy with Voyager DSLT

Efficiency and Efficacy with Voyager DSLT

Christine Funke, MD, provides a first-person view of her experience using direct selective laser trabeculoplasty (DSLT) treatment in the practice with the Voyager DSLT (Alcon). The video shows the patients’ perspectives and illustrates the comfort and efficiency of the procedure.
Play Real-World Patient Cases for DSLT

Real-World Patient Cases for DSLT

Christine Funke, MD, showcases real-world patients undergoing direct selective laser trabeculoplasty (DSLT) with Voyager (Alcon). She explains how easily the device can integrate into a practice, and patients describe their experiences.

Interested in learning more about the Voyager™ DSLT?

Learn More
Alcon Logo

© 2026 Alcon Inc. 3/26
US-DLT-2600024

1. Gazzard, Gus, et al. "Randomized Non-Inferiority Trial of Direct Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension: GLAUrious."Ophthalmology (2025).

Alcon Voyager™ DSLT Important Product Information

Caution: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

Intended Use: Voyager™ DSLT is a prescription device intended for use in performing selective laser trabeculoplasty.

Indications: Voyager™ DSLT is indicated for use in selective laser trabeculoplasty (SLT).

Contraindications:

  • Use of the Voyager™ DSLT device is contraindicated in the following patients: Patients who are unable to fixate their head and/or eyes, such as patients suffering from uncontrolled nystagmus, tremors or similar conditions.
  • Patients with a pupil that cannot constrict to a diameter of 4 mm or less.

Warnings:

  • Users should wear laser safety eyewear while performing a procedure with the Voyager DSLT device to avoid injury to the user's eyes.
  • Use of controls or adjustments or performance of procedures other than those specified herein may result in hazardous laser radiation exposure.
  • Caution should be used when treating patients who have active uveitis or neovascularization that involves the iridocorneal angle with the Voyager DSLT device.
  • The effect of selective laser trabeculoplasty energy on glaucoma implants located in the iridocorneal angle has not been studied. Because your version of the Voyager DSLT device does not allow masking of the implant area (i.e. ability to program a laser pattern which skips the local area of the implant), the use of the device is not recommended in eyes which have a glaucoma implant at any clock hour in the iridocorneal angle.
  • In the pivotal clinical study of the Voyager DSLT device, the safety and effectiveness of re-treatment was not studied; therefore, the level of IOP reduction and potential for complications associated with re-treatment has not been established. Re-treatment is not recommended.

ATTENTION: Refer to the Voyager™ DSLT Directions for Use operating instructions and for the accessories/consumables and User Guide for a complete listing of indications, warnings, cautions and notes.